A new drug to treat psoriasis has been developed and is in clinical testing. Assume that those individuals given the drug are examined before receiving the treatment and then again after receiving the treatment to determine if there was a change in their symptom status. If the initial results showed that 2.0% of individuals entered the study in remission, 77.0% of individuals entered the study with mild symptoms, 16.0% of individuals entered the study with moderate symptoms, and 5.0% entered the study with severe symptoms calculate and interpret a chi-squared test to determine if the drug was effective treating psoriasis given the information below from the final examination. Remission (No Symptoms of Psoriasis) Mild Symptoms of Psoriasis Moderate Symptoms of Psoriasis Severe Symptoms of Psoriasis Total Number of Participants to Receive the Drug Number of Participants 380 520 95 5 1000 A) We reject H0 because 6628.075 is greater than 5.99. We have statistically significant evidence at the alpha equals .05 level to show that the distribution of the severity of psoriasis cases at the end of the clinical trial for the sample is different from the distribution of the severity of psoriasis cases prior to the administration of the drug, suggesting the drug is effective. B) We reject H0 because 6628.075 is greater than 7.81. We have statistically significant evidence at the alpha equals .05 level to show that the distribution of the severity of psoriasis cases at the end of the clinical trial for the sample is different from the distribution of the severity of psoriasis cases prior to the administration of the drug, suggesting the drug is effective. C) We reject H0 because 6628.075 is greater than 9.49. We have statistically significant evidence at the alpha equals .05 level to show that the distribution of the severity of psoriasis cases at the end of the clinical trial for the sample is different from the distribution of the severity of psoriasis cases prior to the administration of the drug, suggesting the drug is effective. D) We reject H0 because 6628.075 is greater than 11.07. We have statistically significant evidence at the alpha equals .05 level to show that the distribution of the severity of psoriasis cases at the end of the clinical trial for the sample is different from the distribution of the severity of psoriasis cases prior to the administration of the drug, suggesting the drug is effective. True/False True or False? For a two-tailed test using z values at the .05% significance level we reject H0 if z ≤ -1.960 or if z ≥ 1.960 True or False? Assume a researcher recruits 150 African American and Caucasian individuals taking warfarin to determine if there is a difference in the mean dosage of the medication needed to cause a decrease in their INR blood test. If the mean dosage for 75 Caucasian individuals required to get their INR blood test in range is 6.1 mg with a standard deviation of 1.7 mg and the mean dosage for 75 African American individuals required to get their INR blood test in range is 4.3 mg with a standard deviation of 0.9 mg, the Sp value obtained while calculating the test statistic is approximately 1.10 mg. True or False? Assume a researcher recruits 150 African American and Caucasian individuals taking warfarin to determine if there is a difference in the mean dosage of the medication needed to cause a decrease in their INR blood test. If the mean dosage for 75 Caucasian individuals required to get their INR blood test in range is 6.1 mg with a standard deviation of 1.7 mg and the mean dosage for 75 African American individuals required to get their INR blood test in range is 4.3 mg with a standard deviation of 0.9 mg, the z value obtained while calculating the test statistic is approximately 9.60. True or False? Assume a researcher recruits 150 African American and Caucasian individuals taking warfarin to determine if there is a difference in the mean dosage of the medication. If the mean dosage for 75 Caucasian individuals required to get their INR blood test in range is 6.1 mg with a standard deviation of 1.7 mg and the mean dosage for 75 African American individuals required to get their INR blood test in range is 4.3 mg with a standard deviation of 0.9 mg, the decision rule for a 10% level of significance would be to reject H0 if z ≤ -1.645 or z ≥ 1.645 True or False? H0 for an ANOVA test often states that all the mean values from the different independent samples are equal.
A new drug to treat psoriasis has been developed and is in clinical testing. Assume that those individuals given the drug are examined before receiving the treatment and then again after receiving the treatment to determine if there was a change in their symptom status. If the initial results showed that 2.0% of individuals entered the study in remission, 77.0% of individuals entered the study with mild symptoms, 16.0% of individuals entered the study with moderate symptoms, and 5.0% entered the study with severe symptoms calculate and interpret a chi-squared test to determine if the drug was effective treating psoriasis given the information below from the final examination. Remission (No Symptoms of Psoriasis) Mild Symptoms of Psoriasis Moderate Symptoms of Psoriasis Severe Symptoms of Psoriasis Total Number of Participants to Receive the Drug Number of Participants 380 520 95 5 1000 A) We reject H0 because 6628.075 is greater than 5.99. We have statistically significant evidence at the alpha equals .05 level to show that the distribution of the severity of psoriasis cases at the end of the clinical trial for the sample is different from the distribution of the severity of psoriasis cases prior to the administration of the drug, suggesting the drug is effective. B) We reject H0 because 6628.075 is greater than 7.81. We have statistically significant evidence at the alpha equals .05 level to show that the distribution of the severity of psoriasis cases at the end of the clinical trial for the sample is different from the distribution of the severity of psoriasis cases prior to the administration of the drug, suggesting the drug is effective. C) We reject H0 because 6628.075 is greater than 9.49. We have statistically significant evidence at the alpha equals .05 level to show that the distribution of the severity of psoriasis cases at the end of the clinical trial for the sample is different from the distribution of the severity of psoriasis cases prior to the administration of the drug, suggesting the drug is effective. D) We reject H0 because 6628.075 is greater than 11.07. We have statistically significant evidence at the alpha equals .05 level to show that the distribution of the severity of psoriasis cases at the end of the clinical trial for the sample is different from the distribution of the severity of psoriasis cases prior to the administration of the drug, suggesting the drug is effective. True/False True or False? For a two-tailed test using z values at the .05% significance level we reject H0 if z ≤ -1.960 or if z ≥ 1.960 True or False? Assume a researcher recruits 150 African American and Caucasian individuals taking warfarin to determine if there is a difference in the mean dosage of the medication needed to cause a decrease in their INR blood test. If the mean dosage for 75 Caucasian individuals required to get their INR blood test in range is 6.1 mg with a standard deviation of 1.7 mg and the mean dosage for 75 African American individuals required to get their INR blood test in range is 4.3 mg with a standard deviation of 0.9 mg, the Sp value obtained while calculating the test statistic is approximately 1.10 mg. True or False? Assume a researcher recruits 150 African American and Caucasian individuals taking warfarin to determine if there is a difference in the mean dosage of the medication needed to cause a decrease in their INR blood test. If the mean dosage for 75 Caucasian individuals required to get their INR blood test in range is 6.1 mg with a standard deviation of 1.7 mg and the mean dosage for 75 African American individuals required to get their INR blood test in range is 4.3 mg with a standard deviation of 0.9 mg, the z value obtained while calculating the test statistic is approximately 9.60. True or False? Assume a researcher recruits 150 African American and Caucasian individuals taking warfarin to determine if there is a difference in the mean dosage of the medication. If the mean dosage for 75 Caucasian individuals required to get their INR blood test in range is 6.1 mg with a standard deviation of 1.7 mg and the mean dosage for 75 African American individuals required to get their INR blood test in range is 4.3 mg with a standard deviation of 0.9 mg, the decision rule for a 10% level of significance would be to reject H0 if z ≤ -1.645 or z ≥ 1.645 True or False? H0 for an ANOVA test often states that all the mean values from the different independent samples are equal.
MATLAB: An Introduction with Applications
6th Edition
ISBN:9781119256830
Author:Amos Gilat
Publisher:Amos Gilat
Chapter1: Starting With Matlab
Section: Chapter Questions
Problem 1P
Related questions
Question
- A new drug to treat psoriasis has been developed and is in clinical testing. Assume that those individuals given the drug are examined before receiving the treatment and then again after receiving the treatment to determine if there was a change in their symptom status. If the initial results showed that 2.0% of individuals entered the study in remission, 77.0% of individuals entered the study with mild symptoms, 16.0% of individuals entered the study with moderate symptoms, and 5.0% entered the study with severe symptoms calculate and interpret a chi-squared test to determine if the drug was effective treating psoriasis given the information below from the final examination.
|
Remission (No Symptoms of Psoriasis) |
Mild Symptoms of Psoriasis |
Moderate Symptoms of Psoriasis |
Severe Symptoms of Psoriasis |
Total Number of Participants to Receive the Drug |
Number of Participants |
380 |
520 |
95 |
5 |
1000 |
- A) We reject H0 because 6628.075 is greater than 5.99. We have statistically significant evidence at the alpha equals .05 level to show that the distribution of the severity of psoriasis cases at the end of the clinical trial for the sample is different from the distribution of the severity of psoriasis cases prior to the administration of the drug, suggesting the drug is effective.
- B) We reject H0 because 6628.075 is greater than 7.81. We have statistically significant evidence at the alpha equals .05 level to show that the distribution of the severity of psoriasis cases at the end of the clinical trial for the sample is different from the distribution of the severity of psoriasis cases prior to the administration of the drug, suggesting the drug is effective.
- C) We reject H0 because 6628.075 is greater than 9.49. We have statistically significant evidence at the alpha equals .05 level to show that the distribution of the severity of psoriasis cases at the end of the clinical trial for the sample is different from the distribution of the severity of psoriasis cases prior to the administration of the drug, suggesting the drug is effective.
- D) We reject H0 because 6628.075 is greater than 11.07. We have statistically significant evidence at the alpha equals .05 level to show that the distribution of the severity of psoriasis cases at the end of the clinical trial for the sample is different from the distribution of the severity of psoriasis cases prior to the administration of the drug, suggesting the drug is effective.
True/False
- True or False? For a two-tailed test using z values at the .05% significance level we reject H0 if z ≤ -1.960 or if z ≥ 1.960
- True or False? Assume a researcher recruits 150 African American and Caucasian individuals taking warfarin to determine if there is a difference in the mean dosage of the medication needed to cause a decrease in their INR blood test. If the mean dosage for 75 Caucasian individuals required to get their INR blood test in
range is 6.1 mg with a standard deviation of 1.7 mg and the mean dosage for 75 African American individuals required to get their INR blood test in range is 4.3 mg with a standard deviation of 0.9 mg, the Sp value obtained while calculating the test statistic is approximately 1.10 mg.
- True or False? Assume a researcher recruits 150 African American and Caucasian individuals taking warfarin to determine if there is a difference in the mean dosage of the medication needed to cause a decrease in their INR blood test. If the mean dosage for 75 Caucasian individuals required to get their INR blood test in range is 6.1 mg with a standard deviation of 1.7 mg and the mean dosage for 75 African American individuals required to get their INR blood test in range is 4.3 mg with a standard deviation of 0.9 mg, the z value obtained while calculating the test statistic is approximately 9.60.
- True or False? Assume a researcher recruits 150 African American and Caucasian individuals taking warfarin to determine if there is a difference in the mean dosage of the medication. If the mean dosage for 75 Caucasian individuals required to get their INR blood test in range is 6.1 mg with a standard deviation of 1.7 mg and the mean dosage for 75 African American individuals required to get their INR blood test in range is 4.3 mg with a standard deviation of 0.9 mg, the decision rule for a 10% level of significance would be to reject H0 if z ≤ -1.645 or z ≥ 1.645
- True or False? H0 for an ANOVA test often states that all the
mean values from the different independent samples are equal.
Expert Solution
This question has been solved!
Explore an expertly crafted, step-by-step solution for a thorough understanding of key concepts.
This is a popular solution!
Trending now
This is a popular solution!
Step by step
Solved in 3 steps with 1 images
Knowledge Booster
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, statistics and related others by exploring similar questions and additional content below.Recommended textbooks for you
MATLAB: An Introduction with Applications
Statistics
ISBN:
9781119256830
Author:
Amos Gilat
Publisher:
John Wiley & Sons Inc
Probability and Statistics for Engineering and th…
Statistics
ISBN:
9781305251809
Author:
Jay L. Devore
Publisher:
Cengage Learning
Statistics for The Behavioral Sciences (MindTap C…
Statistics
ISBN:
9781305504912
Author:
Frederick J Gravetter, Larry B. Wallnau
Publisher:
Cengage Learning
MATLAB: An Introduction with Applications
Statistics
ISBN:
9781119256830
Author:
Amos Gilat
Publisher:
John Wiley & Sons Inc
Probability and Statistics for Engineering and th…
Statistics
ISBN:
9781305251809
Author:
Jay L. Devore
Publisher:
Cengage Learning
Statistics for The Behavioral Sciences (MindTap C…
Statistics
ISBN:
9781305504912
Author:
Frederick J Gravetter, Larry B. Wallnau
Publisher:
Cengage Learning
Elementary Statistics: Picturing the World (7th E…
Statistics
ISBN:
9780134683416
Author:
Ron Larson, Betsy Farber
Publisher:
PEARSON
The Basic Practice of Statistics
Statistics
ISBN:
9781319042578
Author:
David S. Moore, William I. Notz, Michael A. Fligner
Publisher:
W. H. Freeman
Introduction to the Practice of Statistics
Statistics
ISBN:
9781319013387
Author:
David S. Moore, George P. McCabe, Bruce A. Craig
Publisher:
W. H. Freeman